Seongnam, South Korea · Founded 2017 · Privately Held (backing)
Operator of a biotech company intended to develop antibodies and antibody-drug conjugates to overcome drug resistance. Novelty Nobility is based in Seongnam, South Korea and was founded in 2017. Its last known valuation is $10.8 million. It has raised $60.8 million.
Last price · $/share
—
Implied valuation
$10.8M
Total raised
$60.8M
Last round
—
Team — not yet on record
No current team members for Novelty Nobility are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Novelty Nobility with a free account
·The complete investor list: 29 names
·Watch Novelty Nobility: the Monday email on marks, rounds and moves